RxDoctor Payments Data

Sara Movaghar, DO

Geriatric Medicine · Morganton, NCNPI 1114311966

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.5% of the total across 31 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Viatris Specialty LLC at 24.3% of the total.

$644in general payments, 2019–2025

Across 31 payments — averaging $20.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viatris Specialty LLC$157
  • Regeneron Healthcare Solutions, Inc.$95
  • AstraZeneca$74
  • Verona Pharma, Inc.$56
  • Actelion Pharmaceuticals US, Inc.$56
  • United Therapeutics Corporation$54
  • plus $152 from 6 others

What the payments were for

  • Food & beverage$62897%
  • Education$163%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$644 in reported general payments places this provider in the 85th percentile of 138 geriatric medicine providers in North Carolina.

See all geriatric medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$25,311
Medicare patients
124
Services billed
316

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide22$33,864
EliquisApixaban32$28,585
FarxigaDapagliflozin Propanediol11$15,588
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$7,359
Gabapentin91$2,070
ValacyclovirValacyclovir Hcl11$1,314
Levothyroxine Sodium134$1,238
Albuterol Sulfate HfaAlbuterol Sulfate31$1,205
Atorvastatin Calcium115$1,000
Pantoprazole Sodium58$727
Lisinopril111$685
Duloxetine Hcl30$664
Amlodipine Besylate105$621
Tramadol Hcl32$611
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen18$561

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$16$33,86422 claims
PfizerEliquis$22$28,58532 claims
AstraZenecaFarxiga$74$15,58811 claims
ANI Pharmaceuticals, Inc.Valsartan$37$40017 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 138 geriatric medicine providers in North Carolina.

Other geriatric medicine in Morganton

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →